Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1?± Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy

Jie Wei; Hua Jiang; Hongrui Gao; Guangjie Wang

首页> 外文期刊>Cellular Physiology and Biochemistry >Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1?± Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy

【24h】

Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1?± Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy

机译：阻断雷帕霉素（mTOR）的哺乳动物靶标可减弱糖尿病性视网膜病变中的HIF-1？±通路参与的血管内皮生长因子（VEGF）。

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cellular Physiology and Biochemistry》 |2016年第6期|共8页
作者
Jie Wei; Hua Jiang; Hongrui Gao; Guangjie Wang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类细胞生物物理学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI. [J] . Kwonoh Park, Jae-Lyun Lee, Inkeun Park, Medical oncology . 2012,第5期

机译：一线VEGF TKI失败后，转移性肾细胞癌患者中血管内皮生长因子（VEGF）酪氨酸激酶抑制剂（TKI）和哺乳动物靶雷帕霉素（mTOR）抑制剂作为二线治疗的比较疗效。
2. Prevalence and Clinical Significance of Mammalian Target of Rapamycin Phosphorylation (p-mTOR) and Vascular Endothelial Growth Factor (VEGF) in Clear Cell Carcinoma of the Ovary [J] . Nipon Khemapech, Sunaree Pitchaiprasert, Surang Triratanachat Asian Pacific Journal of Cancer Prevention . 2012,第12期

机译：卵霉素磷酸化（P-MTOR）和血管内皮生长因子（VEGF）在卵巢细胞癌中的哺乳动物靶标患病率及临床意义
3. Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway [J] . Tao Yin, Guoping Wang, Sisi He, The Journal of biological chemistry . 2016,第52期

机译：恶性胸腔积液和腹水通过血管内皮生长因子（VEGF）/磷脂酰肌醇3-激酶（PI3K）/ Akt /机械靶的雷帕霉素（MTOR）途径诱导上皮 - 间充质转变和癌症干细胞性质
4. INSULINE LIKE GROWTH FACTOR-1 AND LEUCINE ACTIVATE PIG MYOGENIC SATELLITE CELLS THROUGH MAMMALIAN TARGET OF RAPAMYCIN PATHWAY [C] . L.T.Medeiros, rnJ.C.Pinto, rnE.M.de Castro, Proceedings of 53rd International Congress of Meat Science and Technology . 2007

机译：胰岛素样生长因子-1和亮氨酸通过雷帕霉素途径的哺乳动物靶标激活猪生代卫星细胞
5. Role of PRAS40 in mammalian target of rapamycin (mTOR) modulation in cancer and insulin resistance. [D] . Malla, Ritu. 2016

机译：PRAS40在哺乳动物雷帕霉素靶标（mTOR）调节中的作用在癌症和胰岛素抵抗中。
6. Outcomes of Unselected Patients with Metastatic Clear-Cell Renal Cell Carcinoma Treated with Front-Line Pazopanib Therapy Followed by Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors (VEGFR-TKI) or Mammalian Target of Rapamycin Inhibitors (mTORi): A Single Institution Experience [O] . Marc R. Matrana, Tharakeswara Bathala, Matthew T Campbell, -1

机译：一线帕唑帕尼治疗后再行血管内皮生长因子受体酪氨酸激酶抑制剂（VEGFR-TKI）或雷帕霉素抑制剂（mTORi）靶向治疗的未选患者转移性透明细胞肾细胞癌患者的疗效：单一机构经验
7. Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy [O] . Jie Wei, Hua Jiang, Hongrui Gao, 2016

机译：哺乳动物靶向雷帕霉素（mTOR）减弱糖尿病视网膜病变中HIF-1α通路参与血管内皮生长因子（VEGF）

Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1?± Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy

著录项

相似文献

相关主题

期刊订阅